Evidence map›Paper›PMID 28874603›Full record

ArticleScience signaling2017

Cancer-associated arginine-to-histidine mutations confer a gain in pH sensing to mutant proteins.

Katharine A White, Diego Garrido Ruiz, Zachary A Szpiech, Nicolas B Strauli, Ryan D Hernandez, Matthew P Jacobson, Diane L Barber

Open access · greenAbstract read
In one paragraph

Article in Science signaling, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Evolution of pH-sensitive transcription termination inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  13. Article
  14. pH-regulated single cell migration.Pflugers Archiv : European journal of physiology · 2024
    Review
  15. Phenotypic screen of sixty-eight colorectal cancer cell lines identifies CEACAM6 and CEACAM5 as markers of acid resistance.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Genetic characterization of intramuscular myxomas.Pathology oncology research : POR · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Katharine A WhiteDepartment of Cell and Tissue Biology, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID http://orcid.org/0000-0002-5831-1886
Diego Garrido RuizDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID http://orcid.org/0000-0002-2441-385X
Zachary A SzpiechDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID http://orcid.org/0000-0001-6372-8224
Nicolas B StrauliDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID http://orcid.org/0000-0001-8575-006X
Ryan D HernandezDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA 94143, USA.
Matthew P JacobsonDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94143, USA.ORCID http://orcid.org/0000-0001-6262-655X
Diane L BarberDepartment of Cell and Tissue Biology, University of California, San Francisco, San Francisco, CA 94143, USA. diane.barber@ucsf.edu.ORCID http://orcid.org/0000-0001-7185-9435
University of California, San Francisco · US

Funding

Clinical and Translational Science InstituteUL1TR001872 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COLLARD, HAROLD R, JACOBY, VANESSA · 2016 to 2025
$112.1M
Roles for Intracellular pH Dynamics in CancerR01CA197855 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DIANE L BARBER · 2016 to 2026
$4.2M
Powerful Simulation Tools for the Genomics AgeR01HG007644 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HERNANDEZ, RYAN D. · 2014 to 2018
$2.1M
Retention of somatic mutations in cancers by changes in pH sensingR21CA178706 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BARBER, DIANE L, HERNANDEZ, RYAN D. · 2013 to 2014
$372k
The pH-dependent adaptive advantage for recurrent histidine mutations in cancerF32CA177085 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WHITE, KATHARINE ALICE · 2013 to 2015
$153k
NCATS NIH HHS UL1 TR001872NCI NIH HHS F32 CA177085NCI NIH HHS R01 CA197855NCI NIH HHS R21 CA178706NHGRI NIH HHS R01 HG007644
6 · The paper itself

Abstract

The intracellular pH (pHi) of most cancers is constitutively higher than that of normal cells and enhances proliferation and cell survival. We found that increased pHi enabled the tumorigenic behaviors caused by somatic arginine-to-histidine mutations, which are frequent in cancer and confer pH sensing not seen with wild-type proteins. Experimentally raising the pHi increased the activity of R776H mutant epidermal growth factor receptor (EGFR-R776H), thereby increasing proliferation and causing transformation in fibroblasts. An Arg-to-Gly mutation did not confer these effects. Molecular dynamics simulations of EGFR suggested that decreased protonation of His

Indexed as

MutationArginineBreast NeoplasmsCarcinogenesisCell ProliferationErbB ReceptorsFemaleHistidineHumansHydrogen-Ion ConcentrationProtein ConformationTumor Cells, CulturedTumor Suppressor Protein p53ArginineEGFR protein, humanErbB ReceptorsHistidineTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID28874603
PMCPMC6022362
OpenAlexW2751967288

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.